Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 11-Apr-24 9:17 AM View:  | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 10-Apr-24 | Option Exercise | 1,787 | $30.00 | $53,610.00 | 4% 46.82K to 48.6K | |
| 11-Mar-24 5:34 PM View: | Cormorant Asset Management,... 10% Owner | Corbus Pharmaceuticals Hold... (CRBP) | 08-Mar-24 | Purchase | 300,000 | $44.38 | $13,314,200.00 | 17% 1.73M to 2.02M | |
| 11-Mar-24 5:34 PM View: | Cormorant Asset Management,... 10% Owner | Corbus Pharmaceuticals Hold... (CRBP) | 07-Mar-24 | Purchase | 250,000 | $40.05 | $10,013,400.00 | 17% 1.48M to 1.73M | |
| 29-Feb-24 5:13 PM View: | Smethurst Dominic Chief Medical Officer | Corbus Pharmaceuticals Hold... (CRBP) | 27-Feb-24 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 14-Feb-24 3:19 PM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 12-Feb-24 | Grant | 73,947 | -- | -- | 707% 10.45K to 84.4K | |
| 14-Feb-24 3:26 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 12-Feb-24 | Grant | 40,176 | -- | -- | 605% 6.64K to 46.82K | |
| 06-Feb-24 4:00 PM View: | Cormorant Asset Management,... 10% Owner | Corbus Pharmaceuticals Hold... (CRBP) | 02-Feb-24 | Purchase | 750,000 | $19.00 | $14,250,000.00 | 103% 725.0K to 1.48M | |
| 30-Jan-24 4:23 PM View: | Cormorant Asset Management,... 10% Owner | Corbus Pharmaceuticals Hold... (CRBP) | 26-Jan-24 | Purchase | 282,632 | $32.24 | $9,111,940.00 | 64% 442.37K to 725.0K | |
| 30-Jan-24 6:07 PM View: | Holmer Alan F Director | Corbus Pharmaceuticals Hold... (CRBP) | 26-Jan-24 | Option Exercise | 629 | $4.97 | $3,126.13 | 84% 0.75K to 1.38K | |
| 30-Jan-24 4:56 PM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 26-Jan-24 | Option Exercise | 7,179 | $4.97 | $35,679.60 | 100% 0 to 7.18K | |
| 10-Aug-22 10:16 AM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 10-Aug-22 | Private Purchase | 20,000 | $0.26 | $5,198.00 | 11% 179.27K to 199.27K | |
| 12-Aug-22 9:43 AM View: | Millian Craig Stuart Chief Operating Officer | Corbus Pharmaceuticals Hold... (CRBP) | 10-Aug-22 | Private Purchase | 5,000 | $0.25 | $1,272.50 | 23% 22.0K to 27.0K | |
| 11-Aug-22 9:55 AM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 10-Aug-22 | Private Purchase | 3,800 | $0.26 | $1,003.20 | 4% 94.43K to 98.23K | |
| 16-May-22 10:41 AM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 16-May-22 | Private Purchase | 10,500 | $0.25 | $2,625.00 | 13% 83.93K to 94.43K | |
| 16-May-22 11:03 AM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 16-May-22 | Private Purchase | 12,000 | $0.30 | $3,600.00 | 7% 167.27K to 179.27K | |
| 11-Mar-22 11:23 AM View: | Millian Craig Stuart Chief Operating Officer | Corbus Pharmaceuticals Hold... (CRBP) | 10-Mar-22 | Private Purchase | 10,000 | $0.37 | $3,700.00 | 83% 12.0K to 22.0K | |
| 10-Mar-22 11:47 AM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 10-Mar-22 | Private Purchase | 15,000 | $0.37 | $5,550.00 | 10% 152.27K to 167.27K | |
| 09-Mar-22 10:37 AM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 09-Mar-22 | Private Purchase | 8,600 | $0.37 | $3,182.00 | 11% 75.33K to 83.93K | |
| 22-Dec-20 4:42 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 21-Dec-20 | Planned Option Sale | 87,500 | $1.75 | $153,125.00 | (20%) 437.11K to 349.61K | |
| 22-Dec-20 4:42 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 21-Dec-20 | Option Exercise | 87,500 | $1.40 | $122,500.00 | 25% 349.61K to 437.11K | |
| 22-Dec-20 4:42 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 18-Dec-20 | Planned Option Sale | 53,610 | $1.40 | $75,054.00 | (13%) 403.22K to 349.61K | |
| 22-Dec-20 4:42 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 18-Dec-20 | Option Exercise | 53,610 | $1.00 | $53,610.00 | 15% 349.61K to 403.22K | |
| 18-Dec-20 4:44 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 16-Dec-20 | Planned Option Sale | 36,923 | $1.32 | $48,627.60 | (10%) 386.53K to 349.61K | |
| 18-Dec-20 4:44 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 16-Dec-20 | Option Exercise | 36,923 | $0.17 | $6,118.14 | 11% 349.61K to 386.53K | |
| 12-Nov-20 10:28 AM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 11-Nov-20 | Private Purchase | 4,240 | $1.21 | $5,126.16 | 6% 71.09K to 75.33K | |
| 18-Mar-20 10:37 AM View: | White Barbara Chief Medical Officer | Corbus Pharmaceuticals Hold... (CRBP) | 17-Mar-20 | Private Purchase | 15,606 | $3.63 | $56,649.80 | 8% 190.61K to 206.22K | |
| 17-Mar-20 1:14 PM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 17-Mar-20 | Private Purchase | 4,300 | $3.49 | $15,007.00 | 6% 66.79K to 71.09K | |
| 18-Mar-20 1:18 PM View: | Millian Craig Stuart Chief Commercial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 17-Mar-20 | Private Purchase | 2,000 | $4.25 | $8,500.00 | 20% 10.0K to 12.0K | |
| 18-Mar-20 11:21 AM View: | Discordia Robert Paul Chief Operating Officer | Corbus Pharmaceuticals Hold... (CRBP) | 17-Mar-20 | Private Purchase | 2,840 | $3.54 | $10,053.60 | 9% 32.65K to 35.49K | |
| 13-Nov-19 10:00 AM View: | White Barbara Chief Medical Officer | Corbus Pharmaceuticals Hold... (CRBP) | 12-Nov-19 | Private Purchase | 3,424 | $4.38 | $14,991.60 | 2% 187.19K to 190.61K | |
| 12-Nov-19 1:02 PM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 12-Nov-19 | Private Purchase | 1,430 | $4.26 | $6,091.80 | 2% 65.36K to 66.79K | |
| 12-Nov-19 11:07 AM View: | Millian Craig Stuart Chief Commercial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 11-Nov-19 | Private Purchase | 1,000 | $4.38 | $4,380.00 | 11% 9.0K to 10.0K | |
| 12-Nov-19 9:57 AM View: | Discordia Robert Paul Chief Operating Officer | Corbus Pharmaceuticals Hold... (CRBP) | 11-Nov-19 | Private Purchase | 2,500 | $4.62 | $11,558.50 | 8% 30.15K to 32.65K | |
| 16-Aug-19 9:50 AM View: | Millian Craig Stuart Chief Commercial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 15-Aug-19 | Private Purchase | 1,500 | $5.48 | $8,212.95 | 20% 7.5K to 9.0K | |
| 12-Aug-19 10:18 AM View: | Discordia Robert Paul Chief Operating Officer | Corbus Pharmaceuticals Hold... (CRBP) | 12-Aug-19 | Private Purchase | 15,000 | $5.86 | $87,894.00 | 99% 15.15K to 30.15K | |
| 13-Aug-19 11:46 AM View: | White Barbara Chief Medical Officer | Corbus Pharmaceuticals Hold... (CRBP) | 12-Aug-19 | Private Purchase | 1,639 | $6.10 | $9,997.90 | < 1% 185.55K to 187.19K | |
| 12-Aug-19 10:37 AM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 12-Aug-19 | Private Purchase | 1,175 | $6.06 | $7,115.80 | 2% 64.19K to 65.36K | |
| 13-Aug-19 9:48 AM View: | Millian Craig Stuart Chief Commercial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 12-Aug-19 | Private Purchase | 1,500 | $6.00 | $9,000.00 | 25% 6.0K to 7.5K | |
| 20-May-19 9:48 AM View: | White Barbara Chief Medical Officer | Corbus Pharmaceuticals Hold... (CRBP) | 17-May-19 | Market Purchase | 1,389 | $7.20 | $10,000.80 | < 1% 184.16K to 185.55K | (2%) |
| 14-May-19 1:33 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 14-May-19 | Market Purchase | 100 | $7.12 | $712.00 | < 1% 349.51K to 349.61K | (< 1%) |
| 15-May-19 9:56 AM View: | Millian Craig Stuart Chief Commercial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 14-May-19 | Market Purchase | 1,000 | $7.23 | $7,226.60 | 20% 5.0K to 6.0K | (< 1%) |
| 14-May-19 9:47 AM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 13-May-19 | Market Purchase | 995 | $6.99 | $6,954.85 | 2% 63.19K to 64.19K | 2% |
| 18-Mar-19 9:46 AM View: | Hochman David P Director | Corbus Pharmaceuticals Hold... (CRBP) | 15-Mar-19 | Market Purchase | 2,000 | $6.98 | $13,957.60 | < 1% 702.4K to 704.4K | (4%) |
| 15-Mar-19 11:09 AM View: | Jenkins John Kenneth Director | Corbus Pharmaceuticals Hold... (CRBP) | 15-Mar-19 | Market Purchase | 1,000 | $6.98 | $6,977.90 | 100% 0 to 1.0K | (2%) |
| 14-Mar-19 2:35 PM View: | White Barbara Chief Medical Officer | Corbus Pharmaceuticals Hold... (CRBP) | 14-Mar-19 | Market Purchase | 4,638 | $6.47 | $29,993.90 | 3% 179.52K to 184.16K | 6% |
| 14-Mar-19 11:25 AM View: | Cohen Yuval Chief Executive Officer Director | Corbus Pharmaceuticals Hold... (CRBP) | 14-Mar-19 | Market Purchase | 1,530 | $6.49 | $9,929.70 | 2% 61.66K to 63.19K | 5% |
| 15-Mar-19 10:32 AM View: | Millian Craig Stuart Chief Commercial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 14-Mar-19 | Market Purchase | 5,000 | $6.85 | $34,258.50 | 100% 0 to 5.0K | (< 1%) |
| 14-Mar-19 1:07 PM View: | Moran Sean F. Chief Financial Officer | Corbus Pharmaceuticals Hold... (CRBP) | 14-Mar-19 | Market Purchase | 1,500 | $6.67 | $10,005.00 | < 1% 348.01K to 349.51K | 2% |
| 16-Nov-18 4:09 PM View: | Tepper Mark President and CSO | Corbus Pharmaceuticals Hold... (CRBP) | 14-Nov-18 | Option Exercise | 10,000 | $1.00 | $10,000.00 | < 1% 2.1M to 2.11M | |
| 29-May-18 4:08 PM View: | Hochman David P Director | Corbus Pharmaceuticals Hold... (CRBP) | 24-May-18 | Gift | 220,000 | -- | -- | 31% 702.4K to 922.4K |
